AMP GLOBAL 2025
IN ABU DHABI
AMP GLOBAL 2025
IN ABU DHABI

PROGRAM COMING SOON

REGISTRATION

EXPLORE SPONSORSHIP OPPORTUNITIES

IMPORTANT DATES

Opening Abstract Submission:

November 5, 2024

Opening Registration:

November 5, 2024

Deadline Abstract Submission:

January 15, 2025

Early Bird Deadline:

February 5, 2025

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo.

REASONS TO ATTEND AMP GLOBAL 2025

Access early results


of major molecular diagnostic studies, implementation strategies, quality improvements in patient care, and more.

Stay up-to-date


on advancements in technology by attending industry symposia and exploring exhibits

Connect and network


with fellow molecular pathology professionals in our collegial congress setting.

Find answers


to your questions and discover new paths of scientific inquiry in conversation with molecular experts from around the world

ABOUT THE VENUE

Hilton Abu Dhabi Yas Island

Yas Bay, Yas Island Abu Dhabi, U.A.E.

GET ACCESS TO OUR LATEST NEWS

Stay connected with all of the latest updates by signing up to the mailing list.

By clicking on ‘Subscribe’, you agree to receive the newsletter with information on AMP Global 2025 and to analyze it through individual measurement, storage and evaluation of opening rates and click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. You can revoke your consent at any time for the future as follows. You will find detailed information in our see our privacy statement.

ORGANIZING COMMITTEE

A MESSAGE FROM THE ORGANIZING COMMITTEE CHAIR

We are excited to invite you to attend the Association for Molecular Pathology (AMP) 2025 Global Congress, which will take place April 13-15, 2025 in Abu Dhabi, UAE.

AMP is the leading organization in the field of molecular diagnostics, and our Global Congress is a premier meeting of molecular professionals around the globe. As always, we will explore how cutting-edge technology and developments in molecular testing and diagnostics continue to have a major impact on patient care.

Please be sure to check back for all the latest information. We look forward to seeing you in Abu Dhabi in April 2025!

Chair Yassmine Akkari, PhD
Portland, OR, USA
Nationwide Children's Hospital

Yassmine Akkari

300+ Attendees

30+ Sessions

Scientific
Program

Area

Networking
Events

Yassmine Akkari

Yassmine Akkari, PhD
Portland, OR, USA
Nationwide Children's Hospital

Mafouz_Rami

Vice-Chair

Rami Mafouz, MD, MPH
Beirut, Lebanon
American University of Beirut Medical Center

Imran Mirza

AMP Affiliate

Imran Mirza, MBBS
Abu Dhabi, UAE
Alberta Public Laboratories

Committee Members

Charles Hill

HemePath

Charles Hill, MD, PhD
Atlanta, GA, USA
Emory Univ School of Medicine

Panieh Terraf

Genetics

Panieh Terraf, PhD
New York, NY, USA
Memorial Sloan Kettering Cancer Center (MSKCC)

Infectious Diseases

Heba Mostafa, MD, PhD
Baltimore, MD, USA
Johns Hopkins Medical Institutions

LeonAnnette

Informatics

Annette Leon, PhD, FACMG
Oakland, CA, USA
Fabric Genomics

Soufiane El Hallani_Profile Picture

Solid Tumors

Soufiane El Hallani, MD, PhD
Alberta, CA, Canada
University of Alberta

Robert Best

Tech Topics

Robert Best, PhD
South Carolina, SC, USA
Lab Corp

GET TO KNOW THE ASSOCIATION FOR MOLECULAR PATHOLOGY

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics.

AMP’s 2,900+ members include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees.

MORE ABOUT AMP

Federico Monzon

Federico A. Monzon is a molecular pathologist with extensive experience translating novel genomic technologies into clinical molecular tests, including leading studies on prostate and renal cancer genomics and the validation of one of the first FDA-cleared gene expression clinical assays for the diagnosis of tumors of unknown origin while at the University of Pittsburgh and Houston Methodist Hospital. At Invitae and Baylor Genetics laboratories, he pioneered the use of panel testing for hereditary cancers as well as cancer exome sequencing.

Dr. Monzon is a consultant on medical and scientific strategy for companies in the diagnostic space. Currently, he is Chief Medical Officer (CMO) at Delphi Diagnostics, a laboratory focused on providing genomic tools for the management of breast cancer patients. Prior to that, he served as CMP for Castle Diagnostics and served as Medical Director of Oncology and Medical Director for Latin America at Invitae Corporation. Previously, Dr. Monzon served as Director of Pathology at the Cancer Genetics Laboratory at Baylor College of Medicine. He earned his M.D. from the Universidad Nacional Autónoma de México (UNAM) and is board-certified by the American Board of Pathology in anatomic, clinical and molecular genetic pathology. Dr Monzon was the 2017 President of the Association for Molecular Pathology (AMP) and continues to be engaged in AMP and other professional societies to shape the future of clinical genomic medicine.

Soon!